---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-025787"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2023-06-02T23:59:59+00:00"
generated_at: "2026-06-14T07:58:14.260082+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# RxSight shareholders re-elect three Class II directors, approve charter amendment, ratify auditor

## Summary
- Re-elected William J. Link, Robert Warner, and Shweta Singh Maniar as Class II directors with 24.2M, 21.9M, and 21.2M votes for, respectively.
- Approved certificate of incorporation amendment for officer exculpation under Delaware law: 22.2M for, 2.2M against.
- Ratified Ernst & Young as independent auditor for FY2023: 29.5M for, 3,150 against.
- 87.2% of outstanding shares (29.6M of 33.97M) represented at the June 1, 2023 Annual Meeting.

## SEC filing metadata
- accession: 0000950170-23-025787
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2023-06-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000095017023025787/0000950170-23-025787-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000095017023025787/rxst-20230601.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-025787
- JSON: https://secwatch.observer/filing/0000950170-23-025787.json
- Plain text: https://secwatch.observer/filing/0000950170-23-025787.txt

## Key facts
- Shareholder Votes
  RxSight, Inc. shareholders approved Election of Three Class II Directors at the 2023-06-01 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-01
  source text: 1. Election of Three Class II Directors. The following nominees were re-elected by the holders of our common stock to serve as our Class II directors to hold office until our 2026 annual meeting of stockholders and until their successors have been duly elected and qualified: Nominee For Withhold Broker Non-Votes William J. Link, Ph.D. 24,161,853 253,009 5,195,070 Robert Warner 21,883,075 2,531,787 5,195,070 Shweta Singh Maniar 21,198,960 2,215,902 5,195,070
  evidence_url: https://www.sec.gov/Archives/edgar/data/1111485/000095017023025787/0000950170-23-025787-index.htm
- Shareholder Votes
  RxSight, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-06-01 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-01
  source text: 3. Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified based on the following results of voting: For Against Abstain Broker Non-Votes 29,491,614 3,150 115,168 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1111485/000095017023025787/0000950170-23-025787-index.htm
- Shareholder Votes
  RxSight, Inc. shareholders approved Amendment of the Company's certificate of incorporation to reflect new Delaware law provisions regarding officer exculpation at the 2023-06-01 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2023-06-01
  source text: 2. Amendment of the Company's certificate of incorporation to reflect new Delaware law provisions regarding officer exculpation. The amendment of the Company's certificate of incorporation to reflect new Delaware law provisions regarding officer exculpation was approved based on the following results of voting: For Against Abstain Broker Non-Votes 22,214,405 2,173,831 26,626 5,195,070
  evidence_url: https://www.sec.gov/Archives/edgar/data/1111485/000095017023025787/0000950170-23-025787-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
